CSRxP: Legislative Hearing on Drug Pricing Bills a Positive First Step, Now More Action Needed

03-13-2019 Press Release

Today, members of the U.S. House Committee on Energy & Commerce Subcommittee on Health held a legislative hearing on a number of proposals to tackle skyrocketing drug prices, more evidence of building momentum in Congress to take concrete action. “Today’s hearing was an important first step toward passing bipartisan, market-based solutions like the CREATES Act […]

Questioning The Rebate Rule

03-12-2019 Press Release

Secretary Azar Recently Noted The Effectiveness Of PBMs Now Targeted By Agency Proposal U.S. Department of Health and Human Services (HHS) Secretary Alex Azar will head to Capitol Hill on Tuesday where he will testify on the Trump Administration’s budget proposal before the U.S. House Committee on Energy and Commerce Subcommittee on Health.  During his […]

Trump Administration Should Focus on Market-Based Solutions to Alleviate Drug Prices

03-11-2019 Press Release

As Secretary Azar Heads To Capitol Hill, CSRxP Encourages Lawmakers To Question Budget-Busting $200 Billion Rebate Rule For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Monday ahead of U.S. Department of Health and Human Services Secretary Alex Azar testifying Tuesday on the […]

THEY SAID IT! U.S. House Ways & Means Subcommittee Pushes For Increased Competition To Lower Drug Prices

03-8-2019 Press Release

For Immediate Release  Contact: Jon Conradi 860-235-3884 [email protected] On Thursday, members of the U.S. House Committee on Ways and Means Subcommittee on Health added their voice to the building momentum for action in Washington to bring down the out-of-control price of prescription drugs.  Committee members, of both parties, further agreed swift action is needed to […]

Skyrocketing Drug Prices Place Extreme Financial Burdens On Families

03-7-2019 Press Release

Patients Tell Congress, Paying For Life-Saving Medications Often Means Going Without Basic Needs & Going Into Debt  Five patients testified before the U.S. Senate Special Committee on Aging Wednesday to tell their harrowing stories of how skyrocketing drug prices have impacted their lives and their finances.  This is the first of three hearings this week […]

THEY SAID IT! Senators On Aging Committee Join Call For Action In Washington To Alleviate Rising Burden Of Prescription Drug Prices

03-6-2019 Press Release

For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] On Wednesday, five American patients gave eye-opening testimony to members of the U.S. Senate Special Committee on Aging on the tremendous impact of rising prescription drug prices on their ability to stay healthy and live their lives. Their stories, filled with gut-wrenching sacrifices and dangerous last resorts, […]

CSRxP Praises Gottlieb For Leadership On Drug Pricing

03-6-2019 Press Release

FDA Commissioner Was Invaluable Voice In Favor Of Market-Based Solutions To Increase Competition & Lower Drug Prices For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected]   Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday praising Food and Drug Administration (FDA) Commissioner Gottlieb for his efforts to support and advance market-based […]

Pace Of Drug Price Activity In Congress A Reason For Optimism

03-5-2019 Press Release

Three More Hearings Will Keep Attention On The Impact Of Big Pharma’s Anti-Competitive Tactics For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected]   Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday in anticipation of a trio of hearings before Congress this week that will address the crisis of prescription […]

They Said It: Senators Slam Big Pharma CEOs For Price Gouging, Anti-Competitive Tactics

02-27-2019 Press Release

For Immediate Release  Contact: Jon Conradi 860-235-3884 [email protected] On Tuesday, the U.S. Senate Committee on Finance held its second hearing on drug pricing of the new Congress.  Committee members, of both parties, used their time to emphasize the real and often gut-wrenching effects of rising drug prices on their constituents and reprimand the executives of the seven […]

CSRxP Statement on Testimony of Seven Pharmaceutical Executives Before Senate Finance Committee

02-26-2019 Press Release

For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday after seven pharmaceutical executives testified before the U.S. Senate Committee on Finance in a hearing on rising drug prices: “We thank Chairman Grassley, Ranking Member Wyden and all the members of the committee […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.